Impel NeuroPharma, a Seattle-based, privately-held biopharmaceutical company focused on therapies for the treatment of central…
sciencecityAugust 29, 2018
The emerging form of cancer treatment called CAR T immunotherapy is wiping out the disease…
sciencecityAugust 27, 2018
Humans’ ability to notice moving objects has always been a useful skill, from avoiding an…
sciencecityAugust 24, 2018
Fred Hutchinson Cancer Research Center immunobioengineer Dr. Matthias Stephan has received a 2018 Investigator’s Award in Cell…
sciencecityAugust 23, 2018
Fred Hutchinson Cancer Research Center has received a $1.26 million, five-year Science Education Partnership Award from…
sciencecityAugust 23, 2018
Type 1 diabetes (or T1D) is caused by a selective destruction of the body’s insulin-producing cells…
sciencecityAugust 21, 2018
Seattle Children’s is launching BrainChild with the goal of finding better treatments, or even cures,…
sciencecityAugust 20, 2018
Dr. Charles Murry is the Woods Professor of Pathology, Bioengineering and Medicine/Cardiology at the University…
sciencecityAugust 16, 2018
A clinical trial conducted in six medical centers in the United States has suggested that…
sciencecityAugust 16, 2018
